Staying Up to Date on the Latest Advancements Across Hematologic OncologyByGuenther Koehne, MDMarch 17th 2026Adverse effects of novel immunotherapies appear controllable compared with chemotherapy in hematologic malignancies, according to Guenther Koehne, MD.